CD133 is a stem cell marker that is expressed on a range of solid tumours, including hepatocellular carcinoma, glioblastoma, pancreatic cancer, gastric cancer, colorectal cancer and endothelial cells implicated in neovascularization. The gene discussed is PROM1; the disease is hepatocellular carcinoma.